AGI-1067
CAS No. 216167-82-7
AGI-1067 ( Succinobucol;AGI 1067;AGI1067 )
Catalog No. M13448 CAS No. 216167-82-7
AGI-1067 (Succinobucol) is a potent inhibitor of TNF-α-inducible expression of VCAM-1, MCP-1 and E-selectin (IC50=6,10 and 25 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 147 | In Stock |
|
50MG | 250 | In Stock |
|
100MG | 428 | In Stock |
|
500MG | 945 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAGI-1067
-
NoteResearch use only, not for human use.
-
Brief DescriptionAGI-1067 (Succinobucol) is a potent inhibitor of TNF-α-inducible expression of VCAM-1, MCP-1 and E-selectin (IC50=6,10 and 25 uM).
-
DescriptionAGI-1067 (Succinobucol) is a potent inhibitor of TNF-α-inducible expression of VCAM-1, MCP-1 and E-selectin (IC50=6,10 and 25 uM) with concurrent antioxidant and lipid-modulating properties; inhibits atherosclerosis in LDL receptor-deficient and apolipoprotein E-deficient mice, also reduces VCAM-1 and MCP-1 mRNA levels in lungs of LPS-stimulated mice; inhibits atherosclerosis not only via its lipid-lowering effects but also by having direct anti-inflammatory effects on the vessel wall.Diabetes Phase 3 Clinical
-
SynonymsSuccinobucol;AGI 1067;AGI1067
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number216167-82-7
-
Formula Weight616.92
-
Molecular FormulaC35H52O5S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(O)CCC(OC1=C(C(C)(C)C)C=C(SC(C)(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)C)C=C1C(C)(C)C)=O
-
Chemical Name4-(4-((1-((3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl)sulfanyl)-1-methylethyl)sulfanyl)-2,6-bis(1,1-dimethylethyl)phenoxy)-4-oxobutanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sundell CL, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):1116-23.
2. Meng CQ, et al. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2545-8.
3. Tardif JC, et al. Circulation. 2003 Feb 4;107(4):552-8.
4. Kunsch C, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):820-9.
2. Meng CQ, et al. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2545-8.
3. Tardif JC, et al. Circulation. 2003 Feb 4;107(4):552-8.
4. Kunsch C, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):820-9.
molnova catalog
related products
-
Clocapramine dihydro...
Clocapramine hydrochloride hydrate is an antagonist of the 5-HT2A and D2 receptors.
-
Bocconoline
Bocconoline strongly perturbs various cellular components of human olfactory neurosphere-derived (hONS) cell lines.
-
L-allo-Isoleucine
L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.